Skip to Content
You are currently on the new version of our website. Access the old version .

1,172 Results Found

  • Review
  • Open Access
117 Citations
14,213 Views
19 Pages

p53 Isoforms and Their Implications in Cancer

  • Maximilian Vieler and
  • Suparna Sanyal

25 August 2018

In this review we focus on the major isoforms of the tumor-suppressor protein p53, dysfunction of which often leads to cancer. Mutations of the TP53 gene, particularly in the DNA binding domain, have been regarded as the main cause for p53 inactivati...

(This article belongs to the Special Issue p53 Signaling in Cancers)
  • Review
  • Open Access
38 Citations
7,726 Views
20 Pages

The Δ133p53 Isoforms, Tuners of the p53 Pathway

  • Sebastien M. Joruiz,
  • Jessica A. Beck,
  • Izumi Horikawa and
  • Curtis C. Harris

18 November 2020

The TP53 gene is a critical tumor suppressor and key determinant of cell fate which regulates numerous cellular functions including DNA repair, cell cycle arrest, cellular senescence, apoptosis, autophagy and metabolism. In the last 15 years, the p53...

(This article belongs to the Special Issue The Isoforms of the p53 Gene Family and Their Role in Cancer and Aging:Selection Papers from International p53/p63/p73 Isoforms Workshop)
  • Review
  • Open Access
2 Citations
1,985 Views
32 Pages

p53 Isoforms as Modifiers of the p53-Dependent Responses: A Hidden Code?

  • Laura Bartolomei,
  • Beatrice Pretto,
  • Samuele Brugnara,
  • Alessandra Sontacchi and ,
  • Vanessa Dassi,
  • Aya Bousrih,
  • Chiara Damaggio,
  • Francesca Flangini,
  • Alessandra Bisio and
  • Yari Ciribilli
  • + 5 authors+ 0 author

25 March 2026

The tumor suppressor protein p53, encoded by the TP53 gene, is known as the “Guardian of the Genome”, and alterations in TP53 are common to more than 50% of human cancers. p53 is a critical regulator of cellular responses to several stres...

(This article belongs to the Special Issue Tumor Suppressor Genes and Oncogenes: Genome-Wide Insights into Cancer Biology)
  • Review
  • Open Access
34 Citations
7,917 Views
20 Pages

27 June 2022

This review aims to summarize the implications of the major isoforms of the tumor suppressor protein p53 in aggressive cancer development. The current knowledge of p53 isoforms, their involvement in cell-signaling pathways, and their interactions wit...

(This article belongs to the Special Issue Targeting Therapies for the p53 Protein in Cancer Treatments)
  • Review
  • Open Access
1,348 Views
35 Pages

The p53 Isoforms as Potential Biomarkers in Different Cancer Entities

  • Christine Supina Pavić,
  • Anđela Horvat,
  • Ana Tadijan,
  • Janja Josić and ,
  • Martina Deželjin,
  • Maja Jazvinšćak Jembrek,
  • Ignacija Vlašić and
  • Neda Slade
  • + 3 authors+ 0 author

The p53 protein is a pivotal tumor suppressor that is mutated in more than half of tumor cases in humans. In addition, its activity/function can be perturbed by various other mechanisms. Existence of two promoters in the TP53 gene and extensive splic...

(This article belongs to the Special Issue p53—Oncogene, Tumor Suppressor Gene, Guardian of the Genome and the Cell)
  • Review
  • Open Access
6 Citations
4,138 Views
13 Pages

p53 is a transcription al factor responsible for the maintenance of cellular homeostasis. It has been shown that more than 50% of tumors are connected with mutations in the Tp53 gene. These mutations cause a disturbance in cellular response to stress...

(This article belongs to the Special Issue Renal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches)
  • Review
  • Open Access
66 Citations
12,205 Views
20 Pages

11 December 2019

p53, first described four decades ago, is now established as a master regulator of cellular stress response, the “guardian of the genome”. p53 contributes to biological robustness by behaving in a cellular-context dependent manner, influe...

(This article belongs to the Special Issue p53 in Cancer and beyond—40 Years after Its Discovery)
  • Article
  • Open Access
23 Citations
6,383 Views
25 Pages

Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness

  • Ana Tadijan,
  • Francesca Precazzini,
  • Nikolina Hanžić,
  • Martina Radić and ,
  • Nicolò Gavioli,
  • Ignacija Vlašić,
  • Petar Ozretić,
  • Lia Pinto,
  • Lidija Škreblin and
  • Yari Ciribilli
  • + 7 authors+ 2 authors

18 October 2021

Cutaneous melanoma is the most aggressive form of skin cancer. Despite the significant advances in the management of melanoma in recent decades, it still represents a challenge for clinicians. The TP53 gene, the guardian of the genome, which is alter...

(This article belongs to the Special Issue The Isoforms of the p53 Gene Family and Their Role in Cancer and Aging:Selection Papers from International p53/p63/p73 Isoforms Workshop)
  • Review
  • Open Access
51 Citations
14,007 Views
19 Pages

29 November 2019

Cellular senescence, a term originally used to define the characteristics of normal human fibroblasts that reached their replicative limit, is an important factor for ageing, age-related diseases including cancer, and cell reprogramming. These outcom...

(This article belongs to the Special Issue p53 in Cancer and beyond—40 Years after Its Discovery)
  • Review
  • Open Access
63 Citations
8,783 Views
45 Pages

Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair

  • Anais Blanchet,
  • Agathe Bourgmayer,
  • Jean-Emmanuel Kurtz,
  • Georg Mellitzer and
  • Christian Gaiddon

22 February 2021

Gastric cancer is one of the most aggressive cancers, with a median survival of 12 months. This illustrates its complexity and the lack of therapeutic options, such as personalized therapy, because predictive markers do not exist. Thus, gastric cance...

(This article belongs to the Special Issue The Isoforms of the p53 Gene Family and Their Role in Cancer and Aging:Selection Papers from International p53/p63/p73 Isoforms Workshop)
  • Article
  • Open Access
209 Views
25 Pages

lncRNA MANCR Isoforms Selectively Contribute to Epigenomic and p53-Responsive Transcriptional Control in Triple-Negative Breast Cancer

  • Emory Pacht,
  • Janine S. A. Warren,
  • Rabail H. Toor,
  • Karen C. Glass and ,
  • Haley W. Greenyer,
  • Princess D. Rodriguez,
  • Clara Kugler,
  • Andrew J. Fritz,
  • Bodhisattwa Banerjee and
  • Janet L. Stein
  • + 10 authors+ 5 authors

22 October 2026

Background: Long noncoding RNAs (lncRNAs) are important regulators of gene expression and are frequently dysregulated in cancer. The mitotically associated lncRNA MANCR is highly expressed in aggressive cancers and contributes to genomic instability...

(This article belongs to the Section Long Non-Coding RNA)
  • Article
  • Open Access
5 Citations
2,652 Views
11 Pages

Conserved Double Translation Initiation Site for Δ160p53 Protein Hints at Isoform’s Key Role in Mammalian Physiology

  • Maria José López-Iniesta,
  • Shrutee N. Parkar,
  • Ana Catarina Ramalho,
  • Rafaela Lacerda and ,
  • Inês F. Costa,
  • Jingyuan Zhao,
  • Luísa Romão and
  • Marco M. Candeias
  • + 3 authors+ 0 author

13 December 2022

p53 is the most commonly mutated gene in human cancers. Two fundamental reasons for this are its long protein isoforms protect from cancer, while its shorter C-terminal isoforms can support cancer and metastasis. Previously, we have shown that the &D...

(This article belongs to the Special Issue p53 in Cancer and beyond—40 Years after Its Discovery)
  • Article
  • Open Access
11 Citations
6,095 Views
16 Pages

p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression

  • Luiza Steffens Reinhardt,
  • Kira Groen,
  • Alexandre Xavier and
  • Kelly A. Avery-Kiejda

In breast cancer, p53 expression levels are better predictors of outcome and chemotherapy response than TP53 mutation. Several molecular mechanisms that modulate p53 levels and functions, including p53 isoform expression, have been described, and may...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
13 Citations
3,632 Views
20 Pages

Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer

  • Luiza Steffens Reinhardt,
  • Kira Groen,
  • Brianna C. Morten,
  • Jean-Christophe Bourdon and
  • Kelly A. Avery-Kiejda

TP53 mutations are associated with tumour progression, resistance to therapy and poor prognosis. However, in breast cancer, TP53′s overall mutation frequency is lower than expected (~25%), suggesting that other mechanisms may be responsible for...

(This article belongs to the Special Issue Mutant p53 in Cancer Progression and Personalized Therapeutic Treatments)
  • Article
  • Open Access
11 Citations
6,186 Views
27 Pages

Different Roles of p62 (SQSTM1) Isoforms in Keratin-Related Protein Aggregation

  • Meghana Somlapura,
  • Benjamin Gottschalk,
  • Pooja Lahiri,
  • Iris Kufferath and ,
  • Daniela Pabst,
  • Thomas Rülicke,
  • Wolfgang F. Graier,
  • Helmut Denk and
  • Kurt Zatloukal
  • + 4 authors+ 0 author

p62/Sequestosome-1 (p62) is a multifunctional adaptor protein and is also a constant component of disease-associated protein aggregates, including Mallory–Denk bodies (MDBs), in steatohepatitis and hepatocellular carcinoma. We investigated the intera...

(This article belongs to the Collection Feature Papers in “Molecular Biology”)
  • Article
  • Open Access
8 Citations
3,637 Views
14 Pages

p53 Protein Isoform Profiles in AML: Correlation with Distinct Differentiation Stages and Response to Epigenetic Differentiation Therapy

  • Ingvild Haaland,
  • Sigrun M. Hjelle,
  • Håkon Reikvam,
  • André Sulen and ,
  • Anita Ryningen,
  • Emmet McCormack,
  • Øystein Bruserud and
  • Bjørn Tore Gjertsen
  • + 3 authors+ 0 author

7 April 2021

p53 protein isoform expression has been found to correlate with prognosis and chemotherapy response in acute myeloid leukemia (AML). We aimed to investigate how p53 protein isoforms are modulated during epigenetic differentiation therapy in AML, and...

(This article belongs to the Special Issue Identification of Prognostic Markers in Cancer Biology)
  • Article
  • Open Access
2 Citations
2,088 Views
8 Pages

11 August 2024

Background: The level of the regulator of G-protein signaling 4-1 (RGS4-1) isoform, the longest RGS4 isoform, is significantly reduced in the dorsolateral prefrontal cortex (DLPFC) of people with schizophrenia. However, the mechanism behind this has...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
10 Citations
4,933 Views
12 Pages

The Influence of Quadruplex Structure in Proximity to P53 Target Sequences on the Transactivation Potential of P53 Alpha Isoforms

  • Otília Porubiaková,
  • Natália Bohálová,
  • Alberto Inga,
  • Natália Vadovičová and ,
  • Jan Coufal,
  • Miroslav Fojta and
  • Václav Brázda
  • + 2 authors+ 0 author

24 December 2019

p53 is one of the most studied tumor suppressor proteins that plays an important role in basic biological processes including cell cycle, DNA damage response, apoptosis, and senescence. The human TP53 gene contains alternative promoters that produce...

(This article belongs to the Special Issue p53 in Cancer and beyond—40 Years after Its Discovery)
  • Article
  • Open Access
8 Citations
5,510 Views
16 Pages

YC-1 Antagonizes Wnt/β-Catenin Signaling Through the EBP1 p42 Isoform in Hepatocellular Carcinoma

  • Ju-Yun Wu,
  • Yu-Lueng Shih,
  • Shih-Ping Lin,
  • Tsai-Yuan Hsieh and
  • Ya-Wen Lin

13 May 2019

Novel drugs targeting Wnt signaling are gradually being developed for hepatocellular carcinoma (HCC) treatment. In this study, we used a Wnt-responsive Super-TOPflash (STF) luciferase reporter assay to screen a new compound targeting Wnt signaling. 3...

(This article belongs to the Special Issue Targeting Wnt Signaling in Cancer)
  • Article
  • Open Access
11 Citations
3,477 Views
20 Pages

p73α1, an Isoform of the p73 Tumor Suppressor, Modulates Lipid Metabolism and Cancer Cell Growth via Stearoyl-CoA Desaturase-1

  • Zachary Rabow,
  • Kyra Laubach,
  • Xiangmudong Kong,
  • Tong Shen and ,
  • Shakur Mohibi,
  • Jin Zhang,
  • Oliver Fiehn and
  • Xinbin Chen
  • + 3 authors+ 0 author

13 August 2022

Altered lipid metabolism is a hallmark of cancer. p73, a p53 family member, regulates cellular processes and is expressed as multiple isoforms. However, the role of p73 in regulating lipid metabolism is not well-characterized. Previously, we found th...

(This article belongs to the Special Issue Metabolic Regulation: Cell Growth and Proliferation)
  • Communication
  • Open Access
11 Citations
4,027 Views
20 Pages

Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis

  • Alexandra N. Boix De Jesus,
  • Ahmad Taha,
  • David Wang,
  • Paulomi M. Mehta and ,
  • Sunali Mehta,
  • Ashley Reily-Bell,
  • Sasini Polwatta Lekamlage,
  • Adriana Machado Saraiva,
  • Tahmeed Tahmeedzaman and
  • Tania L. Slatter
  • + 11 authors+ 6 authors

The Δ133p53β isoform is increased in many primary tumors and has many tumor-promoting properties that contribute to increased proliferation, migration and inflammation. Here we investigated whether Δ133p53β contributed to some o...

(This article belongs to the Special Issue Invasion and Metastasis in Brain Cancer)
  • Article
  • Open Access
16 Citations
5,953 Views
23 Pages

4 September 2019

The human cytochrome P450 (CYP) 2C9 and 2C19 enzymes are two highly similar isoforms with key roles in drug metabolism. They are anchored to the endoplasmic reticulum membrane by their N-terminal transmembrane helix and interactions of their cytoplas...

(This article belongs to the Special Issue Cytochromes P450: Drug Metabolism, Bioactivation and Biodiversity 2.0)
  • Article
  • Open Access
3 Citations
3,797 Views
14 Pages

A Comparison of p53 Isoform Profiles and Apoptosis Induced by Camptothecin or a Herbal Khat Extract (Catha Edulis (Vahl) Forssk. ex Endl.) in Leukemic Cell Lines: Exploring Cellular Responses in Therapy Development

  • Therese Bredholt Onyango,
  • Sigrun M. Hjelle,
  • Ingvild Haaland,
  • Olav K. Vintermyr and ,
  • Anne Christine Johannessen and
  • Bjørn Tore Gjertsen
  • + 1 author+ 0 author

1 December 2020

Khat (Catha edulis (Vahl) Forssk. ex Endl.) is habitually used as a natural stimulant by millions of people, but is associated with adverse effects on gastrointestinal, cardiovascular and central neural systems. At the cellular level khat toxicity in...

(This article belongs to the Special Issue The Isoforms of the p53 Gene Family and Their Role in Cancer and Aging:Selection Papers from International p53/p63/p73 Isoforms Workshop)
  • Review
  • Open Access
24 Citations
5,479 Views
15 Pages

Redox Sensitive Cysteine Residues as Crucial Regulators of Wild-Type and Mutant p53 Isoforms

  • Elena Butturini,
  • Giovanna Butera,
  • Raffaella Pacchiana,
  • Alessandra Carcereri de Prati and ,
  • Sofia Mariotto and
  • Massimo Donadelli
  • + 1 author+ 0 author

12 November 2021

The wild-type protein p53 plays a key role in preventing the formation of neoplasms by controlling cell growth. However, in more than a half of all cancers, the TP53 gene has missense mutations that appear during tumorigenesis. In most cases, the mut...

(This article belongs to the Special Issue Cancer Therapy Based on Oxidative Stress Modulation)
  • Article
  • Open Access
5 Citations
3,302 Views
22 Pages

Novel Isoform DTX3c Associates with UBE2N-UBA1 and Cdc48/p97 as Part of the EphB4 Degradation Complex Regulated by the Autocrine IGF-II/IRA Signal in Malignant Mesothelioma

  • Pierluigi Scalia,
  • Carmen Merali,
  • Carlos Barrero,
  • Antonio Suma and ,
  • Vincenzo Carnevale,
  • Salim Merali and
  • Stephen J. Williams
  • + 2 authors+ 0 author

EphB4 angiogenic kinase over-expression in Mesothelioma cells relies upon a degradation rescue signal provided by autocrine IGF-II activation of Insulin Receptor A. However, the identity of the molecular machinery involved in EphB4 rapid degradation...

(This article belongs to the Section Molecular Oncology)
  • Feature Paper
  • Review
  • Open Access
17 Citations
7,952 Views
42 Pages

p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies

  • Anđela Horvat,
  • Ana Tadijan,
  • Ignacija Vlašić and
  • Neda Slade

9 June 2021

The p53 tumor suppressor protein is crucial for cell growth control and the maintenance of genomic stability. Later discovered, p63 and p73 share structural and functional similarity with p53. To understand the p53 pathways more profoundly, all famil...

(This article belongs to the Special Issue The Tumor Suppressor TP53 in Colorectal Carcinoma)
  • Review
  • Open Access
11 Citations
4,966 Views
16 Pages

15 December 2023

The transcription factor c-Myc, a key regulator of cellular processes, has long been associated with roles in cell proliferation and apoptosis. This review analyses the multiple functions of c-Myc by examining the different c-Myc isoforms in detail....

(This article belongs to the Section Molecular Genetics and Genomics)
  • Review
  • Open Access
26 Citations
5,897 Views
22 Pages

Good Cop, Bad Cop: Defining the Roles of Δ40p53 in Cancer and Aging

  • Luiza Steffens Reinhardt,
  • Xiajie Zhang,
  • Anna Wawruszak,
  • Kira Groen and ,
  • Geoffry N. De Iuliis and
  • Kelly A. Avery-Kiejda
  • + 1 author+ 0 author

23 June 2020

The tumour suppressor p53 is essential for maintaining DNA integrity, and plays a major role in cellular senescence and aging. Understanding the mechanisms that contribute to p53 dysfunction can uncover novel possibilities for improving cancer therap...

(This article belongs to the Special Issue The Isoforms of the p53 Gene Family and Their Role in Cancer and Aging:Selection Papers from International p53/p63/p73 Isoforms Workshop)
  • Review
  • Open Access
28 Citations
6,380 Views
16 Pages

p53 Family in Resistance to Targeted Therapy of Melanoma

  • Ignacija Vlašić,
  • Anđela Horvat,
  • Ana Tadijan and
  • Neda Slade

Metastatic melanoma is one of the most aggressive tumors, with frequent mutations affecting components of the MAPK pathway, mainly protein kinase BRAF. Despite promising initial response to BRAF inhibitors, melanoma progresses due to development of r...

(This article belongs to the Special Issue Molecular Research and New Therapy in Melanoma and Other Skin Cancers)
  • Article
  • Open Access
2 Citations
1,326 Views
19 Pages

29 December 2025

The ferredoxin reductase (FDXR) gene is expressed as seven isoforms: 1–6 by alternative splicing and 7 by an alternative promoter according to the Entrez Gene Database. Previous studies showed that FDXR, primarily the mitochondrial isoform 1, p...

(This article belongs to the Special Issue Mitochondria at the Crossroad of Health and Disease—Second Edition)
  • Article
  • Open Access
6 Citations
5,833 Views
27 Pages

Deciphering the Nature of Trp73 Isoforms in Mouse Embryonic Stem Cell Models: Generation of Isoform-Specific Deficient Cell Lines Using the CRISPR/Cas9 Gene Editing System

  • Lorena López-Ferreras,
  • Nicole Martínez-García,
  • Laura Maeso-Alonso,
  • Marta Martín-López and ,
  • Ángela Díez-Matilla,
  • Javier Villoch-Fernandez,
  • Hugo Alonso-Olivares,
  • Margarita M. Marques and
  • Maria C. Marin
  • + 4 authors+ 0 author

25 June 2021

The p53 family has been widely studied for its role in various physiological and pathological processes. Imbalance of p53 family proteins may contribute to developmental abnormalities and pathologies in humans. This family exerts its functions throug...

(This article belongs to the Special Issue The Isoforms of the p53 Gene Family and Their Role in Cancer and Aging:Selection Papers from International p53/p63/p73 Isoforms Workshop)
  • Article
  • Open Access
18 Citations
4,292 Views
9 Pages

Computational Prediction of Inhibitors and Inducers of the Major Isoforms of Cytochrome P450

  • Anastassia Rudik,
  • Alexander Dmitriev,
  • Alexey Lagunin,
  • Dmitry Filimonov and
  • Vladimir Poroikov

10 September 2022

Human cytochrome P450 enzymes (CYPs) are heme-containing monooxygenases. This superfamily of drug-metabolizing enzymes is responsible for the metabolism of most drugs and other xenobiotics. The inhibition of CYPs may lead to drug–drug interacti...

(This article belongs to the Special Issue Recent Trends on Enzymes Inhibitors and Activators in Drug Research 3.0)
  • Article
  • Open Access
2 Citations
3,028 Views
13 Pages

Cytotoxicity of Frutalin on Distinct Cancer Cells Is Independent of Its Glycosylation

  • Carla Oliveira,
  • Ana Isabel Freitas,
  • Nair Campos,
  • Lucília Saraiva and
  • Lucília Domingues

4 August 2021

Frutalin is a plant lectin with beneficial immunobiological action, although the access to its active form is still restricted. Moreover, there is a knowledge gap on isoform activity and glycosylation impact on its bioactivity, and recombinant produc...

(This article belongs to the Section Bioorganic Chemistry)
  • Article
  • Open Access
2 Citations
2,686 Views
14 Pages

New Approach for Studying of Isoforms and High-Homology Proteins in Mammalian Cells

  • Nataliya V. Soshnikova,
  • Yuriy P. Simonov,
  • Alexey V. Feoktistov,
  • Alvina I. Khamidullina and ,
  • Margarita A. Yastrebova,
  • Darya O. Bayramova,
  • Victor V. Tatarskiy and
  • Sofia G. Georgieva
  • + 3 authors+ 0 author

In mammals, a large number of proteins are expressed as more than one isoform, resulting in the increased diversity of their proteome. Understanding the functions of isoforms is very important, since individual isoforms of the same protein can have o...

(This article belongs to the Special Issue Structure, Function and Dynamics in Proteins)
  • Review
  • Open Access
23 Citations
5,787 Views
6 Pages

Targeting MDM4 Splicing in Cancers

  • Boris Bardot and
  • Franck Toledo

20 February 2017

MDM4, an essential negative regulator of the P53 tumor suppressor, is frequently overexpressed in cancer cells that harbor a wild‐type P53. By a mechanism based on alternative splicing, the MDM4 gene generates two mutually exclusive isoforms:...

(This article belongs to the Special Issue Therapeutic Alternative Splicing: Mechanisms and Applications)
  • Article
  • Open Access
3 Citations
4,923 Views
44 Pages

27 September 2020

Polypharmacy, potentially inappropriate medications (PIMs) identified by the American Geriatrics Society and Screening Tool of Older People’s Prescriptions (STOPP), potential prescribing omissions (PPOs) identified by Screening Tool to Alert to...

(This article belongs to the Section Geriatric Psychiatry and Psychology)
  • Article
  • Open Access
80 Citations
9,422 Views
20 Pages

Cytochrome c Oxidase Subunit 4 Isoform Exchange Results in Modulation of Oxygen Affinity

  • David Pajuelo Reguera,
  • Kristýna Čunátová,
  • Marek Vrbacký,
  • Alena Pecinová and ,
  • Josef Houštěk,
  • Tomáš Mráček and
  • Petr Pecina
  • + 2 authors+ 0 author

14 February 2020

Cytochrome c oxidase (COX) is regulated through tissue-, development- or environment-controlled expression of subunit isoforms. The COX4 subunit is thought to optimize respiratory chain function according to oxygen-controlled expression of its isofor...

(This article belongs to the Section Intracellular and Plasma Membranes)
  • Article
  • Open Access
15 Citations
4,271 Views
20 Pages

Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition

  • Erhan Aptullahoglu,
  • Carmela Ciardullo,
  • Jonathan P. Wallis,
  • Helen Marr and ,
  • Scott Marshall,
  • Nick Bown,
  • Elaine Willmore and
  • John Lunec
  • + 3 authors+ 0 author

26 January 2023

Several molecular subtypes of cancer are highly dependent on splicing for cell survival. There is a general interest in the therapeutic targeting of splicing by small molecules. E7107, a first-in-class spliceosome inhibitor, showed strong growth inhi...

(This article belongs to the Section Molecular Oncology)
  • Brief Report
  • Open Access
398 Views
11 Pages

22 September 2026

Background: Variants of uncertain significance (VUSs) in TP53 and CDKN2A are reported often in oral squamous cell carcinoma (OSCC), yet variant-level evidence tends to lag behind established gene-level associations. Candidate variant lists compiled b...

(This article belongs to the Special Issue New Insight of Genetic Alterations in Head and Neck and Salivary Gland Tumor)
  • Article
  • Open Access
3 Citations
2,166 Views
13 Pages

11 February 2024

Vacuolar ATPases (V-ATPases), proton pumps composed of 16 subunits, are necessary for a variety of cellular functions. Subunit “a” has four isoforms, a1–a4, each with a distinct cellular location. We identified a phosphoinositide (P...

(This article belongs to the Special Issue Biomolecular Structure, Function and Interactions)
  • Review
  • Open Access
101 Citations
16,386 Views
23 Pages

The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer

  • Laura García-Hernández,
  • María Belén García-Ortega,
  • Gloria Ruiz-Alcalá,
  • Esmeralda Carrillo and ,
  • Juan Antonio Marchal and
  • María Ángel García
  • + 1 author+ 0 author

29 December 2021

The mitogen-activated protein kinase (MAPK) family is an important bridge in the transduction of extracellular and intracellular signals in different responses at the cellular level. Within this MAPK family, the p38 kinases can be found altered in va...

(This article belongs to the Special Issue Activity, Function and Druggability of Cancer-Related Enzymes)
  • Review
  • Open Access
13 Citations
5,434 Views
15 Pages

p53, A Victim of the Prion Fashion

  • Olivier Billant,
  • Gaëlle Friocourt,
  • Pierre Roux and
  • Cécile Voisset

13 January 2021

Identified in the late 1970s as an oncogene, a driving force leading to tumor development, p53 turned out to be a key tumor suppressor gene. Now p53 is considered a master gene regulating the transcription of over 3000 target genes and controlling a...

(This article belongs to the Special Issue The Isoforms of the p53 Gene Family and Their Role in Cancer and Aging:Selection Papers from International p53/p63/p73 Isoforms Workshop)
  • Review
  • Open Access
283 Views
23 Pages

Targeting PAK1 Within Group I PAKs: Current Challenges and Pharmacological Perspectives

  • George Nicolae Daniel Ion,
  • Cosmina Gabriela Duta-Bratu,
  • Dragos Paul Mihai and
  • George Mihai Nitulescu

14 October 2026

The p21-activated kinase 1 (PAK1) has been investigated as a therapeutic target for more than two decades, particularly in cancer, where it contributes to cytoskeletal regulation, proliferation, survival, migration and therapy resistance. Despite the...

(This article belongs to the Special Issue Computer-Aided Drug Design and Drug Discovery, 2nd Edition)
  • Article
  • Open Access
20 Citations
5,019 Views
10 Pages

Tau N-Terminal Inserts Regulate Tau Liquid-Liquid Phase Separation and Condensates Maturation in a Neuronal Cell Model

  • Chengchen Wu,
  • Junyi Zhao,
  • Qiuping Wu,
  • Qiulong Tan and ,
  • Qiong Liu and
  • Shifeng Xiao
  • + 1 author+ 0 author

8 September 2021

The microtubule-associated protein tau can undergo liquid–liquid phase separation (LLPS) to form membraneless condensates in neurons, yet the underlying molecular mechanisms and functions of tau LLPS and tau droplets remain to be elucidated. The huma...

(This article belongs to the Special Issue Protein Structure Dynamics and Function)
  • Article
  • Open Access
5 Citations
3,662 Views
16 Pages

Characterization of a PIP Binding Site in the N-Terminal Domain of V-ATPase a4 and Its Role in Plasma Membrane Association

  • Anh Chu,
  • Yeqi Yao,
  • Golam T. Saffi,
  • Ji Hyun Chung and ,
  • Roberto J. Botelho,
  • Miroslawa Glibowicka,
  • Charles M. Deber and
  • Morris F. Manolson
  • + 3 authors+ 0 author

Vacuolar ATPases (V-ATPases) are multi-subunit ATP-dependent proton pumps necessary for cellular functions, including pH regulation and membrane fusion. The evidence suggests that the V-ATPase a-subunit’s interaction with the membrane signaling...

(This article belongs to the Special Issue Biochemistry, Molecular Biology and Druggability of Proteins)
  • Article
  • Open Access
19 Citations
4,265 Views
14 Pages

Hydrophilic Poly(glutamic acid)-Based Nanodrug Delivery System: Structural Influence and Antitumor Efficacy

  • Yifei Guo,
  • Yiping Shen,
  • Bo Yu,
  • Lijuan Ding and ,
  • Zheng Meng,
  • Xiaotong Wang,
  • Meihua Han,
  • Zhengqi Dong and
  • Xiangtao Wang
  • + 4 authors+ 0 author

31 May 2022

Poly(amino acids) have advanced characteristics, including unique secondary structure, enzyme degradability, good biocompatibility, and stimuli responsibility, and are suitable as drug delivery nanocarriers for tumor therapy. The isoform structure of...

(This article belongs to the Section Biobased and Biodegradable Polymers)
  • Article
  • Open Access
4 Citations
3,222 Views
14 Pages

Increased Expression of NPM1 Suppresses p27Kip1 Function in Cancer Cells

  • Tatsuya Kometani,
  • Takuya Arai and
  • Taku Chibazakura

8 October 2020

p27Kip1, a major cyclin-dependent kinase inhibitor, is frequently expressed at low levels in cancers, which correlates with their malignancy. However, in this study, we found a qualitative suppression of p27 overexpressed in some cancer cells. By pro...

(This article belongs to the Special Issue Cell Cycle and Cell Cycle Checkpoint Deregulations: From Oncogenic Drivers to Therapeutic Targets)
  • Article
  • Open Access
5 Citations
3,195 Views
12 Pages

The Target Therapy Hyperbole: “KRAS (p.G12C)”—The Simplification of a Complex Biological Problem

  • Massimiliano Chetta,
  • Anna Basile,
  • Marina Tarsitano,
  • Maria Rivieccio and ,
  • Maria Oro,
  • Nazzareno Capitanio,
  • Nenad Bukvic,
  • Manuela Priolo and
  • Alessandra Rosati
  • + 4 authors+ 0 author

28 June 2024

Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) gene variations are linked to the development of numerous cancers, including non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and pancreatic ductal adenocarcinoma (PDAC). The lack of typic...

(This article belongs to the Section Cancer Drug Development)
  • Article
  • Open Access
24 Citations
5,223 Views
23 Pages

P38 MAPK Promotes Migration and Metastatic Activity of BRAF Mutant Melanoma Cells by Inducing Degradation of PMCA4b

  • Randa Naffa,
  • Lisa Vogel,
  • Luca Hegedűs,
  • Katalin Pászty and ,
  • Sarolta Tóth,
  • Kornélia Kelemen,
  • Neha Singh,
  • Attila Reményi,
  • Enikő Kállay and
  • Ágnes Enyedi
  • + 8 authors+ 3 authors

13 May 2020

Metastatic melanoma is the most aggressive type of skin cancer. Previously, we identified the plasma membrane Ca2+ pump isoform 4b (PMCA4b or ATP2B4) as a putative metastasis suppressor in BRAF mutant melanoma cells. Metastasis suppressors are often...

(This article belongs to the Section Cell Signaling)
  • Article
  • Open Access
12 Citations
5,535 Views
19 Pages

The Cellular Localization of the p42 and p46 Oligoadenylate Synthetase 1 Isoforms and Their Impact on Mitochondrial Respiration

  • Stig Skrivergaard,
  • Monica Skou Jensen,
  • Tine Breckling Rolander,
  • Tram Bao Ngoc Nguyen and ,
  • Amanda Bundgaard,
  • Lene N. Nejsum and
  • Pia M. Martensen
  • + 2 authors+ 0 author

4 December 2019

The importance of the IFN-induced oligoadenylate synthetase (OAS) proteins and the OAS/RNase L pathway in the innate response against viral pathogens is well-established, however the observed differences in anti-viral activity between the human OAS1...

of 24